CliffBio
small molecule

ELYXYB

CELECOXIB

Loss of exclusivityMay 2036latest FDA-listed patent expiry
CompanyScilex Pharmaceuticals →View the full company profile on CliffBio

Drug detail

Brand nameELYXYB
Active ingredientCELECOXIB
Strength25MG/ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalMay 2020
Marketing statusRX

Listed patents

PatentExpiresType
10722456May 2036product
10799517May 2036product
9949990May 2036product
9795620May 2036product
9572819May 2036product
10376527May 2036product

More from Scilex Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

ELYXYB patent cliff — loss of exclusivity May 2036 | CliffBio